e-learning
resources
Vienna 2003
Monday 29.09.2003
Surgery for chest neoplasms and VATS
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Feasibility of intraoperative imprint cytology for evaluation of N status in lung cancer
S. Urek, A. Orki, C. S. Dudu, Z. Yalcin, K. Temurturkan, B. Arman (Istanbul, Turkey)
Source:
Annual Congress 2003 - Surgery for chest neoplasms and VATS
Session:
Surgery for chest neoplasms and VATS
Session type:
Poster Discussion
Number:
2312
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Urek, A. Orki, C. S. Dudu, Z. Yalcin, K. Temurturkan, B. Arman (Istanbul, Turkey). Feasibility of intraoperative imprint cytology for evaluation of N status in lung cancer. Eur Respir J 2003; 22: Suppl. 45, 2312
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Concordance between rapid on-site evaluation (ROSE) and final diagnosis in patients undergoing endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007
Yield of real-time EBUS-TBNA in the diagnosis and staging of lung cancer
Source: Annual Congress 2005 - New techniques in diagnostic and therapeutic interventional pulmonology
Year: 2005
Improving lung cancer staging with EUS-FNA
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Usefulness of liquid-based cytology for detection of central early lung cancer in a high risk group
Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer
Year: 2010
CT-guided transthoracic fine-needle aspiration vs core needle biopsy in diagnosis of lung cancer: A retrospective comparison of diagnostic accuracy
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
Evaluate the use of transthoracic fine-needle aspiration biopsy in diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 325s
Year: 2001
Endoscopic assessment
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006
Negative predictive value of real-time endobronchial ultrasound-guided transbronchial needle aspiration in staging non-small cell lung cancer
Source: Annual Congress 2010 - Waves and needles: ultrasound guided diagnostic
Year: 2010
Systematic staging through endobronchial ultrasound-guided transbronchial needle aspiration compared with targeted staging in patients with non-small cell lung cancer.
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Evaluation of the transbronchial flexible-needle aspiration biopsy in lung cancer diagnostics
Source: Eur Respir J 2001; 18: Suppl. 33, 327s
Year: 2001
EBUS combined with EUS-B for a complete endoscopic staging of lung cancer
Source: Virtual Congress 2021 – Interventional pulmonology
Year: 2021
Combination of CT-guided core biopsy with rapid-on-site-evaluation of imprint cytology enables time and cost savings in diagnosis of peripheral lung tumors
Source: Annual Congress 2012 - Solitary pulmonary nodules in the age of lung cancer screening: up and coming endoscopic options
Year: 2012
The efficacy of cytology sampling in the diagnosis of suspected endobronchial lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
Adequacy of EBUS-TBNA specimens for molecular testing in lung adenocarcinoma
Source: International Congress 2017 – EBUS
Year: 2017
Implementation of EUS-FNA for lung cancer staging
Source: Eur Respir J 2007; 30: Suppl. 51, 109s
Year: 2007
Radial probe EBUS versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: an economic analysis
Source: Eur Respir J 2013; 41: 539-547
Year: 2013
Transbronchial/transesophageal bronchoscopic ultrasound-guided fine needle aspiration for mediastinal staging of non-small cell lung cancer
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept